Top compounds associated with response to RUNX1


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib CTRPv2 pan-cancer AAC 0.089 0.02
mRNA FTI-277 GDSC1000 pan-cancer AAC 0.086 0.02
mRNA BRD-K50799972 CTRPv2 pan-cancer AAC 0.096 0.02
mRNA ruxolitinib CTRPv2 pan-cancer AAC 0.088 0.02
mRNA GDC-0941 CTRPv2 pan-cancer AAC -0.092 0.02
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC 0.086 0.02
mRNA skepinone-L CTRPv2 pan-cancer AAC -0.13 0.02
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.02
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.091 0.02
Download CSV